甘肃皓天医药科技有限责任公司

甘肃皓天医药科技有限责任公司

甘肃省白银市白银区重庆路11号

甘肃皓天医药科技有限责任公司是甘肃省最大的专业从事高活原料药、化学药中间体产品研发、生产、销售，CDMO/CMO技术服务的高新技术企业，也是国内知名的技术开发企业。化学催化技术和生物催化技术是公司的技术特色，公司目前已形成骨化醇、抗抑郁症、抗真菌、心血管和JAK抑制剂五大特色系列产品。

730900

(3R,4R)-1-Benzyl-N,4-diMethylpiperidin-3-Amine dihydrochloride（1062580-52-2）;(3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine ((2R,3R)-2,3-bis((4-methylbenzoyl)oxy)succinate) (2:1)（477600-71-8）;7H-Pyrrolo[2,3-d]pyrimidin-4-amine,N-methyl-N-[(3R,4R)-4-methyl-1-(phenylmethyl)-3-piperidinyl]-7-[(4-methylphenyl)sulfonyl]​-（923036-30-0）;4-Chloropyrrolo[2,3-d]pyrimidine（3680-69-1）;2,4-Dichloro-7H-pyrrolo[2,3-d]pyrimidine（90213-66-4）;tofacitinib citrate（540737-29-9）;(S)-3-(dimethylamino)-1-(thiophen-2-yl)propan-1-ol（132335-44-5）;(S)-3-(methylamino)-1-(thiophen-2-yl)propan-1-ol（116539-55-0）;1-fluoronaphthalene（321-38-0）;(S)-indoline-2-carboxylate（79815-20-6）;(2S,3aS,7aS)-Octahydro-1H-indole-2-carboxylic Acid（80875-98-5）;N-[(S)-1-Carbethoxy-1-butyl]-(S)-alanine（82834-12-6）;(2S,3aS,7aS)-benzyl octahydro-1H-indole-2-carboxylate p-toluenesulfonic acid（94062-52-9）;5-(2-fluorophenyl)-1H-Pyrrole-3-carboxaldehy（881674-56-2）;2-(2-butyl-4-methyl-6-oxo-1,6-dihydropyrimidin-5-yl)-N,N-dimethylacetamide（1315478-13-7）;(R,E)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpent-2-enoic acid（1012341-48-8）;(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpentanoic acid（1012341-50-2）;Everolimus（159351-69-6）;Benzene, 4-bromo-1-chloro-2-[(4-ethoxyphenyl)methyl]-（461432-23-5）;(5R-cis)-Toluene-4-sulfonic acid 5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-yl)methyltetrahydrofuran-3-ylmethyl ester（149809-43-8）;1-((2S,3S)-2-(benzyloxy)pentan-3-yl)-4-(4-(4-(4-hydroxyphenyl)piperazin-1-yl)phenyl)-1H-1,2,4-triazol-5(4H)-one（184177-83-1）;L-5-Methyletrahydrofolate calcium salt（151533-22-1）;11-chloro-2,3-dihydro-2-methyl-1H-Dibenz[2,3:6,7]oxepino[4,5-c]pyrrol-1-one（1012884-46-6）;Oseltamivir phosphate（204255-11-8）;(3R,4R,5S)-Ethyl 4-(N-(tert-butyl)acetamido)-5-(diallylamino)-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate hydrochloride（651324-08-2）;Cis-2,6-Dimethylmorpholine（6485-55-8）;2-Thiopheneacetyl chloride（39098-97-0）;Ethyl 8-chlorooctanoate（105484-55-7）;Ethyl 8-bromooctanoate（29823-21-0）;sodium,8-[(2-hydroxybenzoyl)amino]octanoate（203787-91-1）;Alfacalcidol（41294-56-8）;Doxercalciferol（54573-75-0）;Calcipotriol monohydrate（147657-22-5）;Paricalcitol（131918-61-1）;Tacalcitol（57333-96-7）;Maxacalcitol（103909-75-7）;Calcitriol（32222-06-3）;Falecalcitriol（83805-11-2）;Eldecalcitol（104121-92-8）;5-(2-Fluorophenyl)-1H-pyrrole-3-carbaldehyde（881674-56-2）;N'-((2S,3S)-2-(Benzyloxy)pentan-3-yl)formohydrazide oxalate（1887197-42-3）;(5R-cis)-Toluene-4-sulfonic acid 5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-yl)methyltetrahydrofuran-3-ylmethyl ester（149809-43-8）;[S-(R',R')]-2,3-Bis(benzoyloxy)butanedioic acid compd. with [S-(R',R')]-[1-ethyl-2-(phenylmethoxy)propyl]hydrazine（183871-36-5）;2-Bromo-4-cyanoacetophenone（20099-89-2）;(2R,3R)-3-(2,5-Difluorophenyl)-3-hydroxy-2-Methyl-4-(1H-1,2,4-triazol-1-yl)thiobutyraMide（368421-58-3）;3-Chloromethyl-1-methyl-1H-[1,2,4]triazole hydrochloride（135206-76-7）;Ethyl 8-bromooctanoate(29823-21-0);sodium,8-[(2-hydroxybenzoyl)amino]octanoate（203787-91-1）

第二十三届世界制药原料中国展

2025-03-06至2025-07-31

E7P02

Active Pharmaceutical Ingredients;Intermediates & Fine Chemicals;Excipients & Drug Formulation;CMO & CRO